Hrt Financial LP sold $28k of CMND
owner at Clearmind Medicine Inc.. 225,191 shares at an average of $0.12, traded Jun 11, 2026, filed Jun 12, 2026.
Score components
- +12Role10% owner
- +5Trade size$28k at market
- +5Share of holdings soldSold 11% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001475597-26-000080, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | POpen-market purchase Common Stock | +2,159,052 | $0.15 | $330k | 2,063,266 | Jun 12, 2026 |
| Jun 11, 2026 | SOpen-market sale Common Stock | -225,191 | $0.12 | $28k | 1,838,075 | Jun 12, 2026 |
Related signals
Other insiders at Clearmind Medicine Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | CMNDsell Clearmind Medicine Inc. | Hrt Financial LP owner | $73k 22,139 shares | -21% | |
| 12Weak | CMNDsell Clearmind Medicine Inc. | Hrt Financial LP owner | $11k 3,183 shares | -3% | |
| 12Weak | CMNDsell Clearmind Medicine Inc. | Hrt Financial LP owner | $7,063 2,102 shares | -2% | |
| 30Weak | CMNDbuy Clearmind Medicine Inc. | Hrt Financial LP owner | $330k 2,159,052 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.